Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Genetic Technologies (GTG), a genetic testing and reproductive services business, has executed a settlement and license agreement with respect to its non-coding patents with San Diego, California-based Gen-Probe.
Subscribe to our email newsletter
The license granted by Genetic Technologies covers the world-wide activities of Gen-Probe in relation to its genetic diagnostics and analysis products.
Discussions between Genetic Technologies and Gen-Probe commenced as a result of Genetic Technologies’ patent infringement suit, filed in the US District Court, Western District of Wisconsin.
Paul MacLeman, CEO of Genetic Technologies, said: “We are pleased that in this instance the parties have, through good faith efforts on both sides, been able to avoid litigation and have come to a mutually agreeable outcome.
“We remain committed to working with other companies that utilise our technology to regularise their activities and trust we can come to similar understandings with those parties in due course.”